Divisiong of Nephrology and Hypertension




Suzanne G. Watnick, MD

Suzanne G. Watnick, MD
Associate Professor of Medicine
Fellowship Program Director
Acting Chief of Nephrology, VA Medical Center

Back to faculty page



Suzanne G. Watnick, MD

Dr. Watnick joined the OHSU Nephrology staff in 2002. Her clinical interests include chronic dialysis, ICU nephrology, and quality of life among patients with chronic kidney disease. She is the Medical Director of the dialysis unit at the Portland Veterans Administration Medical Center and the Training Program Director for the nephrology fellowship program at OHSU. She sits on the Renal Field Advisory Panel for the Office of Veterans Affairs, and is a member of the Dialysis Advisory Group for the American Society of Nephrology.

She participates in clinical research on several fronts. She is interested in quality of life among patients on dialysis, examining the relationships between depression and chronic illness in this population. She has participated as a Site Investigator for the VA/NIH collaborative ATN Trial (Acute Renal Failure Trials Network), the largest study to date looking at acute kidney injury in the intensive care unit. She is also a Site Investigator for the Nephron-D trial, a large prospective randomized control trial, looking at angiotensin receptor blockers plus ACE inhibitors versus angiotensin receptor blockers plus placebo for the progression of diabetic nephropathy. This research has been funded through the Portland Veterans Administration Medical Center, the Medical Research Foundation of Oregon, and the National VA Cooperative Studies Program.


BA - Harvard University, 1990
MD - University of Massachusetts Medical School, 1995


Internal Medicine - University of California, San Francisco, 1995-1998


Nephrology - University of California, San Francisco, 1999
Nephrology - Yale University, 1999 - 2002
Robert Wood Johnson Clinical Scholars Program - Yale University, 2000-2002

Research Interest:

Depression and quality-of-life issues among patients on dialysis

Clinical Interest:

Chronic kidney disease, end-stage renal disease

Representative Publications:
  • Watnick S . Academic Etiquette for the Nephrologist. Clin J Am Soc Neph, In press
  • Hertig A, Watnick S, Strevens H, Boulanger H, Berkane N, Rondeau E. How should women with pre-eclampsia be followed up? New insights from mechanistic studies. Nat Clin Pract Neph, 4:503-509, 2008
  • Palevsky P, Zhang JH, O'Connor TZ, Chertow GM, Crowley ST, Choudhury D, Finkel K, Kellum JA, Paganini E, Schein RMH, Smith MW, Swanson KM, Thompson BT, Vijayan A, Watnick S, Star R, Peduzzi P. Intensity of Renal Support in Critically Ill Patients with Acute Kidney Injury. N Engl J Med, 359(1):7-20, 2008
  • Stenstrom D, Muldoon L, Armijo-Medina H, Watnick S, Doolittle N, Kaufman J, Peterson D, Bubalo J, Neuwelt E. N-Acetylcysteine Use to Prevent Contrast Medium–induced Nephropathy: Premature Phase III Trials. J Vasc Int Radiol, 19:309-318, 2008
  • Watnick S , Stooksbury M, Winter R, Cohen D. White Thrombus Formation in Blood Tubing Lines in a Chronic Hemodialysis Unit. Clin J Am Soc Nephrol, 3:382-386, 2008
  • Osama Hussein Kamel Mohamed, Ihab M. Wahba, Suzanne Watnick, Sandra B. Earle, William M. Bennett, James W. Ayres, and Myrna Y. Munar. Administration of Tobramycin in the Beginning of the Hemodialysis Session: A Novel Intradialytic Dosing Regimen. Clin J Am Soc Nephrol, 2:694-699, 2007
  • Hackett A, Watnick S. Withdrawal from Dialysis in End-Stage Renal Disease: Medical, Social, and Psychological Issues. Seminars in Dialysis, 20(1):86-90, 2007
  • Watnick S , Wang P, Demadura T, Ganzini L. Validation of Two Depression Screening Tools in Dialysis Patients. Am J Kidney Dis, 46:919-924, 2005.
  • Subramanya R, Houghton D, Watnick S. Steroid-responsive idiopathic glomerular capillary endotheliosis: case report and literature review. Am J Kidney Dis, 45:1090-1095, 2005
  • Wang P, Watnick S. Depression: A Common But Under-Recognized Condition Associated with End-Stage Renal Disease. Seminars In Dialysis, 17:237-241;2004
  • Smith GL, Vaccarino V, Kosiborod M, Lichtman J, Cheng S, Watnick SG and Krumholz HM.   Worsening renal function: What is a clinically meaningful change in creatinine during hospitalization with heart failure? Journal of Cardiac Failure, 9:13-25; 2003
  • Troidle L, Watnick S, Wuerth D, Gorban-Brennan N, Kliger A, Finkelstein F. Depression and Its Association With Peritonitis In CPD Patients. Am J Kidney Dis, 42:350-354;2003
  • Watnick S , Mahnensmith R, Kirwin P, Concato J. The Prevalence and Treatment of Depression Among Patients Starting Dialysis. Am J Kidney Dis, 41:105-110;2003
  • Finkelstein FO, Watnick S, Finkelstein S, Wuerth D. The Treatment of Depression In Patients Maintained on Dialysis. J Psychomsomatic Res, 53:957-960;2002
  • Juergensen PH, Zemchenkov A, Watnick S, Finkelstein S, Wuerth D, Finkelstein FO. Comparison of quality-of-life assessment in Russia and the United States in chronic peritoneal dialysis patients. Advances In Peritoneal Dialysis, 18:55-57;2002


  • Watnick S , Morrison G. “The Kidney”. In Current Medical Diagnosis & Treatment, Tierney L, McPhee S, Papadakis M, (eds). New York: Appleton & Lange, 1999, 2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009
  • Watnick S , Morrison G. "The Kidney" in Current Medical Consult. McPhee S, Papadakis M (eds) New York, The McGraw Hill Company, 2006. [Paper and electronic version]
  • Watnick S . "Renal/Acid-Base" In Saint-Frances Guide to Inpatient Medicine, Saint S, Frances C, (eds). Baltimore: Williams & Wilkins, 2 nd edition, 2003
  • Watnick S .“Genitourinary and Renal Disorders.” In Essentials of Diagnosis and Treatment. Tierney L, Saint S, Whooley M, (eds). New York: Appleton & Lange, 2 nd edition, 2002